Rebecca Mincheff
Family · Toledo, OHNPI 1841803541
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,289, more than ten times the $94 reported in 2021. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $99.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$888
- AstraZeneca$587
- Jazz Pharmaceuticals Inc.$433
- Teva Pharmaceuticals USA, Inc.$367
- Sanofi-aventis U.S. LLC$344
- Otsuka America Pharmaceutical, Inc.$336
- plus $5K from 34 others
What the payments were for
- Food & beverage$7,461100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $888 |
| AstraZeneca | 6 | $587 |
| Jazz Pharmaceuticals Inc. | 4 | $433 |
| Teva Pharmaceuticals USA, Inc. | 4 | $367 |
| Sanofi-aventis U.S. LLC | 3 | $344 |
| Otsuka America Pharmaceutical, Inc. | 3 | $336 |
| Johnson & Johnson | 3 | $335 |
| Alkermes, Inc. | 4 | $335 |
| Axsome Therapeutics, Inc. | 3 | $246 |
| Inspire Medical Systems, Inc. | 3 | $231 |
| Novo Nordisk | 2 | $208 |
| Aimmune Therapeutics, Inc. | 2 | $171 |
| SK Life Science, Inc. | 2 | $171 |
| Lilly USA, LLC | 2 | $154 |
| Inari Medical, Inc. | 1 | $151 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Argenx US, Inc. | 1 | $125 |
| Bridgebio Pharma, Inc. | 1 | $124 |
| Madrigal Pharmaceuticals | 1 | $124 |
| Eisai Inc. | 1 | $123 |
| Vanda Pharmaceuticals Inc. | 1 | $122 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $120 |
| Amgen | 1 | $118 |
| Medtronic | 1 | $117 |
| Neurocrine Biosciences, Inc. | 1 | $117 |
| Stryker | 1 | $116 |
| Sage Therapeutics, LLC | 1 | $112 |
| Bayer | 1 | $103 |
| Lundbeck LLC | 1 | $102 |
| Boehringer Ingelheim | 1 | $101 |
| Ipsen Biopharmaceuticals, Inc | 1 | $91 |
| Sanofi | 1 | $90 |
| E.r. Squibb & Sons, L.L.C. | 1 | $86 |
| GSK | 1 | $85 |
| Gilead | 1 | $77 |
| Phathom Pharmaceuticals, Inc. | 1 | $72 |
| Biogen | 1 | $69 |
| Lexicon Pharmaceuticals, Inc. | 1 | $66 |
| Harmony Biosciences LLC | 1 | $64 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,461 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Other family in Toledo
- Kirt MunsonToledo$108K
- Sheri LukeToledo$31K
- Kyle PatchenToledo$25K
- Alexander NorwoodToledo$17K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.